Fueled by a handful of trials and word-of-mouth buzz, low-dose naltrexone is gaining momentum among patients and some doctors ...

An expert in gout clinical trials questions whether ethical considerations for such trials need updating to emphasize patient ...

A combination of budesonide and pulmonary surfactant is associated with better prevention of bronchopulmonary dysplasia in ...

The cumulative use of strong anticholinergics is associated with an increased risk for dementia in a dose-response pattern; ...

Exposure to antenatal corticosteroids is associated with an increased risk for infections among children born preterm and ...

Higher GP empathy shows similar associations with patient-reported outcomes in both telephone and face-to-face consultations, ...

In two multicenter trials, separate balloon angioplasty platforms were noninferior to lithotripsy for treatment of calcified ...

High baseline troponin levels in patients with end-stage kidney disease can predict cardiovascular risk following transplant ...

An individual patient-level meta-analysis shows that tenecteplase, a next-generation thrombolytic, is at least as effective ...

While acknowledging the challenges to using SDOH information in practice, a presenter at the American College of Rheumatology ...

Women (adjusted odds ratio [aOR], 1.86; 95% CI, 1.36-2.96) and individuals with health insurance (aOR, 3.19; 95% CI, ...

The winner of a 2025 SITC grant examines mechanisms that may help explain why drugs that work for some forms of lymphoma ...